Molecule Information
General Information of the Molecule (ID: Mol01075)
Name |
rRNA adenine N-6-methyltransferase ermE (ERME)
,Saccharopolyspora erythraea
|
||||
---|---|---|---|---|---|
Synonyms |
NMT; Erythromycin resistance protein; Macrolide-lincosamide-streptogramin B resistance protein; SACE_0733
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
ermE
|
||||
Sequence |
MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELR
PDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAE PPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTW PLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNI QASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRT GGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRR GPSGGGRTGGRPGRRGGPGQR Click to Show/Hide
|
||||
Function |
This protein produces a dimethylation of the adenine residue at position 2085 in 23S rRNA, resulting in reduced affinity between ribosomes and macrolide-lincosamide-streptogramin B antibiotics.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
5 drug(s) in total
Clarithromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Clarithromycin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
Clindamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Clindamycin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Erythromycin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
Lincomycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Lincomycin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
Telithromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Telithromycin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
Clinical Trial Drug(s)
1 drug(s) in total
Pristinamycin IA
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1], [2], [3] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Pristinamycin IA | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli AS19 | 562 | ||
Escherichia coli AS19-RrmA- | 562 | |||
Escherichia coli DH10B | 316385 | |||
Escherichia coli JC7623 | 562 | |||
Experiment for Drug Resistance |
Agar dilution method assay | |||
Mechanism Description | Methylation of specific nucleotides in rRNA is one of the means by which bacteria achieve resistance to macrolides-lincosamides-streptogramin B (MLSB) and ketolide antibiotics.ErmE dimethylation confers high resistance to all the MLSB and ketolide drugs. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.